A61K 38/164
From bacteria
Official title: {from bacteria}
A61K38/164 (From bacteria) appears on 1,115 US grants and 1,732 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,115
- Published applications
- 1,732
- Assignees
- 854
- Inventors
- 2,875
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 5 | 0 |
| 1990 | 9 | 0 |
| 1991 | 14 | 0 |
| 1992 | 6 | 0 |
| 1993 | 11 | 0 |
| 1994 | 6 | 0 |
| 1995 | 1 | 0 |
| 1996 | 11 | 0 |
| 1997 | 7 | 0 |
| 1998 | 22 | 0 |
| 1999 | 18 | 0 |
| 2000 | 13 | 0 |
| 2001 | 11 | 7 |
| 2002 | 22 | 24 |
| 2003 | 11 | 30 |
| 2004 | 17 | 45 |
| 2005 | 9 | 35 |
| 2006 | 14 | 62 |
| 2007 | 17 | 46 |
| 2008 | 18 | 49 |
| 2009 | 23 | 68 |
| 2010 | 28 | 53 |
| 2011 | 25 | 58 |
| 2012 | 39 | 52 |
| 2013 | 44 | 83 |
| 2014 | 42 | 78 |
| 2015 | 66 | 96 |
| 2016 | 62 | 115 |
| 2017 | 58 | 78 |
| 2018 | 65 | 97 |
| 2019 | 68 | 112 |
| 2020 | 71 | 101 |
| 2021 | 74 | 109 |
| 2022 | 42 | 80 |
| 2023 | 44 | 75 |
| 2024 | 43 | 71 |
| 2025 | 40 | 65 |
| 2026 | 31 | 43 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Polymeric forms of H-NOX proteins6 Oct 2026US 12,753,222 B2Omniox.Inc.
- Immunomodulatory and oncolytic minicells and methods of use22 Sep 2026US 12,741,010 B2Vaxiion Therapeutics, Inc.
- Conjugates of guide RNA-Cas protein complex22 Sep 2026US 12,742,162 B2
- Composition for prevention or treatment of Staphylococcus aureus infectious disease15 Sep 2026US 12,734,212 B2Clipsbnc Co., Ltd.
- Clostridium difficile antigens25 Aug 2026US 12,714,742 B2MicroPharm Limited
- Composition including propionibacterium freudenreichii mj2 strainderived extracellular vesicles or chaperonin protein as active ingredient for prevention, alleviation, or treatment of rheumatoid arthritis8 Oct 2026US 2026/0306557 A1Korea University Research and Business Foundation
- Mucosal vaccines against tuberculosis8 Oct 2026US 2026/0306604 A1University of Houston System
- Shrimp feed and methods of use thereof1 Oct 2026US 2026/0293937 A1Organicin Scientific, Inc.
- Dissolvable microneedle delivery systems for bioactive compounds1 Oct 2026US 2026/0294792 A1Yubeck, Inc.
- Dissolvable microneedle delivery systems for bioactive compounds1 Oct 2026US 2026/0294793 A1Yubeck, Inc.
Most cited
By later US patents
- Chemically modified protein with polyethyleneglycol631US 4,791,192 ATakeda Chemical Industries, Ltd. · 1988
- Immunostimulatory combinations138US 7,387,271 B23M Innovative Properties Company · 2008
- Systems and methods for delivery of a therapeutic agent105US 7,608,275 B2The Foundry, LLC · 2009
- Synthetic peptide and its uses95US 5,698,449 ANorthwestern University · 1997
- Method of treating ischemic tissue92US 5,089,260 AEmory University · 1992